SL-650472

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameSL-650472
Drug Alias Name曲兰色林SL-650472SL-65.0472
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor antagonistsSerotonin 1b (5-HT1b) receptor antagonists
TargetsSerotonin 1b (5-HT1b) receptorSerotonin 2a (5-HT2a) receptor
Therapy Area/IndicationsIntermittent Claudication
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[9] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi
Active IndicationsN/A
Inactive IndicationsIntermittent Claudication

Other Information

ATC CodeN/A
Related LinksN/A